X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/everest-medicines-announces-commercial-launch-and-first-prescription-for-xerava-in-china-301886863.html
https://www.prnewswire.com/news-releases/everest-medicines-announces-approval-of-xerava-in-china-for-the-treatment-of-complicated-intra-abdominal-infections-in-adult-patients-301774097.html
https://www.prnewswire.com/news-releases/everest-medicines-announces-approval-of-xerava-in-hong-kong-for-the-treatment-of-complicated-intra-abdominal-infections-301643527.html
https://www.nasdaq.com/press-release/la-jolla-pharmaceutical-company-announces-exclusive-licensing-agreement-for
https://www.prnewswire.com/news-releases/som-biotech-announces-poster-presentation-on-the-repurposing-of-eravacycline-for-the-treatment-of-sars-cov-2-301158065.html
https://www.globenewswire.com/news-release/2020/07/28/2069027/0/en/La-Jolla-Pharmaceutical-Company-Announces-the-Closing-of-Acquisition-of-Tetraphase-Pharmaceuticals-Inc.html
https://endpts.com/as-it-happened-a-bidding-war-for-an-antibiotic-maker-in-a-market-that-has-ravaged-its-peers/
https://endpts.com/minerva-suffers-another-cns-defeat-eli-lilly-wins-ok-for-tau-based-alzheimers-diagnostic/
https://endpts.com/eli-lilly-vet-kerry-blanchard-takes-the-helm-at-one-of-chinas-top-dealmakers-steering-toward-first-approvals/
https://www.biospace.com/article/releases/tetraphase-pharmaceuticals-to-present-xerava-eravacycline-data-at-idweek-2019/?s=95
https://www.ema.europa.eu/documents/product-information/xerava-epar-product-information_en.pdf
https://endpts.com/tetraphase-plots-q4-launch-for-first-antibiotic-after-long-awaited-ok-for-eravacycline/
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004237/smops/Positive/human_smop_001334.jsp&mid=WC0b01ac058001d127
https://www.biospace.com/article/novartis-taps-shyft-analytics-to-drive-company-s-digital-transformation/
https://globenewswire.com/news-release/2018/01/02/1277285/0/en/Tetraphase-Pharmaceuticals-Announces-Submission-of-New-Drug-Application-to-FDA-for-Eravacycline-for-the-Treatment-of-Complicated-Intra-Abdominal-Infections-cIAI.html
https://www.fiercepharma.com/manufacturing/novasep-moves-eravacycline-api-to-commercial-scale-production
https://www.in-pharmatechnologist.com/Article/2017/12/13/Novasep-to-supply-ingredient-for-Tetraphase-s-candidate-superbug-buster-eravacycline
https://www.novasep.com/home/about-novasep/media-events/press-release/novasep-signs-manufacturing-agreement-with-tetraphase-for-eravacycline-api.html
Market Place
Share 
